Management	0	10	O
of	11	13	O
early	14	19	O
and	20	23	O
advanced	24	32	O
colorectal	33	43	B-Pathological_formation
cancer	44	50	I-Pathological_formation
:	50	51	O
therapeutic	52	63	O
issues	64	70	O
.	70	71	O

PURPOSE	73	80	O
:	80	81	O
The	82	85	O
staging	86	93	O
of	94	96	O
colorectal	97	107	B-Pathological_formation
cancer	108	114	I-Pathological_formation
,	114	115	O
therapeutic	116	127	O
decision	128	136	O
making	137	143	O
in	144	146	O
the	147	150	O
management	151	161	O
of	162	164	O
early	165	170	O
and	171	174	O
advanced	175	183	O
colorectal	184	194	B-Pathological_formation
cancer	195	201	I-Pathological_formation
,	201	202	O
and	203	206	O
dilemmas	207	215	O
posed	216	221	O
by	222	224	O
drug	225	229	O
-	229	230	O
related	230	237	O
toxicity	238	246	O
are	247	250	O
discussed	251	260	O
.	260	261	O

SUMMARY	262	269	O
:	269	270	O
Staging	271	278	O
of	279	281	O
colorectal	282	292	B-Pathological_formation
cancer	293	299	I-Pathological_formation
occurs	300	306	O
after	307	312	O
surgery	313	320	O
and	321	324	O
is	325	327	O
based	328	333	O
on	334	336	O
the	337	340	O
extent	341	347	O
of	348	350	O
disease	351	358	O
invasiveness	359	371	O
and	372	375	O
dissemination	376	389	O
.	389	390	O

Surgery	391	398	O
is	399	401	O
the	402	405	O
primary	406	413	O
treatment	414	423	O
for	424	427	O
stage	428	433	O
I	434	435	O
disease	436	443	O
.	443	444	O

Adjuvant	445	453	O
chemotherapy	454	466	O
is	467	469	O
recommended	470	481	O
after	482	487	O
resection	488	497	O
in	498	500	O
selected	501	509	O
high	510	514	O
-	514	515	O
risk	515	519	O
patients	520	528	B-Organism
with	529	533	O
stage	534	539	O
II	540	542	O
disease	543	550	O
and	551	554	O
in	555	557	O
all	558	561	O
patients	562	570	B-Organism
with	571	575	O
stage	576	581	O
III	582	585	O
disease	586	593	O
.	593	594	O

Convenience	595	606	O
of	607	609	O
administration	610	624	O
,	624	625	O
tolerability	626	638	O
,	638	639	O
and	640	643	O
patient	644	651	B-Organism
factors	652	659	O
not	660	663	O
necessarily	664	675	O
age	676	679	O
may	680	683	O
be	684	686	O
considerations	687	701	O
in	702	704	O
decisions	705	714	O
about	715	720	O
adjuvant	721	729	O
therapy	730	737	O
after	738	743	O
resection	744	753	O
.	753	754	O

Treatment	755	764	O
of	765	767	O
stage	768	773	O
IV	774	776	O
colorectal	777	787	B-Pathological_formation
cancer	788	794	I-Pathological_formation
is	795	797	O
based	798	803	O
on	804	806	O
the	807	810	O
type	811	815	O
of	816	818	O
prior	819	824	O
therapy	825	832	O
and	833	836	O
patient	837	844	B-Organism
-	844	845	O
specific	845	853	O
factors	854	861	O
.	861	862	O

Recently	863	871	O
,	871	872	O
significant	873	884	O
improvements	885	897	O
in	898	900	O
survival	901	909	O
have	910	914	O
been	915	919	O
achieved	920	928	O
through	929	936	O
the	937	940	O
use	941	944	O
of	945	947	O
combination	948	959	O
chemotherapy	960	972	O
and	973	976	O
monoclonal	977	987	O
antibody	988	996	O
regimens	997	1005	O
.	1005	1006	O

Bevacizumab	1007	1018	B-Drug_or_compound
in	1019	1021	O
combination	1022	1033	O
with	1034	1038	O
chemotherapy	1039	1051	O
is	1052	1054	O
first	1055	1060	O
-	1060	1061	O
line	1061	1065	O
therapy	1066	1073	O
for	1074	1077	O
stage	1078	1083	O
IV	1084	1086	O
disease	1087	1094	O
.	1094	1095	O

Age	1096	1099	O
alone	1100	1105	O
should	1106	1112	O
not	1113	1116	O
preclude	1117	1125	O
the	1126	1129	O
use	1130	1133	O
of	1134	1136	O
chemotherapy	1137	1149	O
in	1150	1152	O
stage	1153	1158	O
IV	1159	1161	O
colorectal	1162	1172	B-Pathological_formation
cancer	1173	1179	I-Pathological_formation
,	1179	1180	O
although	1181	1189	O
the	1190	1193	O
ability	1194	1201	O
to	1202	1204	O
tolerate	1205	1213	O
drug	1214	1218	O
-	1218	1219	O
related	1219	1226	O
toxicity	1227	1235	O
may	1236	1239	O
be	1240	1242	O
a	1243	1244	O
consideration	1245	1258	O
.	1258	1259	O

The	1260	1263	O
optimal	1264	1271	O
duration	1272	1280	O
of	1281	1283	O
chemotherapy	1284	1296	O
in	1297	1299	O
patients	1300	1308	B-Organism
with	1309	1313	O
early	1314	1319	O
and	1320	1323	O
metastatic	1324	1334	O
colorectal	1335	1345	B-Pathological_formation
cancer	1346	1352	I-Pathological_formation
is	1353	1355	O
unclear	1356	1363	O
.	1363	1364	O

CONCLUSION	1365	1375	O
:	1375	1376	O
The	1377	1380	O
optimal	1381	1388	O
approach	1389	1397	O
to	1398	1400	O
the	1401	1404	O
treatment	1405	1414	O
of	1415	1417	O
colorectal	1418	1428	B-Pathological_formation
cancer	1429	1435	I-Pathological_formation
depends	1436	1443	O
on	1444	1446	O
several	1447	1454	O
considerations	1455	1469	O
,	1469	1470	O
including	1471	1480	O
patient	1481	1488	B-Organism
-	1488	1489	O
specific	1489	1497	O
factors	1498	1505	O
.	1505	1506	O

